华泰柏瑞国证疫苗与生物科技ETF(159646)资产负债表
| |
2023-12-31 |
2023-06-30 |
2022-12-31 |
| 资产 |
| 银行存款 |
- |
618,630.47 |
683,940.98 |
| 结算备付金 |
113,984.58 |
107,985.46 |
124,151.22 |
| 存出保证金 |
11,780.12 |
5,415.74 |
125,706.32 |
| 交易性金融资产 |
17,559,128.58 |
25,915,091.21 |
52,579,483.56 |
| 其中：股票投资 |
17,559,128.58 |
25,915,091.21 |
52,579,483.56 |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
- |
149,723.84 |
| 应收利息 |
- |
- |
- |
| 应收股利 |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
| 其他资产 |
- |
- |
- |
| 资产总计 |
20,286,440.62 |
26,647,122.88 |
53,663,005.92 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
205,816.88 |
17,197.89 |
- |
| 应付赎回款 |
- |
- |
- |
| 应付管理人报酬 |
8,109.23 |
11,753.43 |
21,714.87 |
| 应付托管费 |
1,621.83 |
2,350.70 |
4,342.97 |
| 应付销售服务费 |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
1,747,125.85 |
146,056.52 |
282,749.82 |
| 负债合计 |
1,962,673.79 |
177,358.54 |
308,807.66 |
| 所有者权益 |
| 实收基金 |
22,707,502.00 |
33,707,502.00 |
56,707,502.00 |
| 未分配利润 |
-4,383,735.17 |
-7,237,737.66 |
-3,353,303.74 |
| 所有者权益合计 |
18,323,766.83 |
26,469,764.34 |
53,354,198.26 |
| 负债及所有者权益总计 |
20,286,440.62 |
26,647,122.88 |
53,663,005.92 |
微信公众号
证券之星APP
基本资料
